Huijie Yang
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dementia Burden and Modifiable Risk Factors in Type 2 Diabetes: Population Based, Prospective Cohort Study.
Journal: Diabetes, obesity & metabolism
Published: December 18, 2025
Henagliflozin enhances frontal neural activation and cognitive function versus gliclazide in type 2 diabetes patients with mild cognitive impairment: A 16-week randomized controlled trial.
Journal: Journal of endocrinological investigation
Published: August 20, 2025
Olfactory training improves cognition and modifies brain networks in type 2 diabetes patients with mild cognitive impairment: A 16-week randomised controlled trial.
Journal: Diabetes, obesity & metabolism
Published: July 24, 2025
Impact of serum prolactin on cognitive function, brain structure, and function in type 2 diabetes mellitus.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 20, 2025
Elevated plasma concentrations of pigment epithelium-derived factor in type 2 diabetic patients is reduced by metformin treatment in association with weight loss 2.
Journal: Journal of diabetes
Published: April 01, 2015
Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetes.
Journal: Acta diabetologica
Published: April 03, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026